suspended in H 2 O (750 mL), then partitioned with EtOAc (3  1 L) to afford the EtOAc crude extract (49.0 g). The extract was fractionated by quick columm chromatography over silica gel (60-200 m, 15  12 cm, 20 mL/min) with a gradient of EtOAc-hexane (from 10 to 50%, 1 L each). Fractions of 100 mL were collected and monitored by TLC, and 13 fractions (I-XIII) were obtained. Fraction V (2200-2800 mL, 1.3 g) was rechromatographed on a silica gel column (40-63 m, 2.5  35 cm, 2.0 mL/min) with 2-10% of acetone-CH 2 Cl 2 , then subfraction V.3 (275-525 mL, 180.0 mg) was further purified using the same procedure (40-63 m, 1.5  30 cm, 1.0 mL/min) with 1% of MeOH-CH 2 Cl 2 to give 31 (30.6 mg). Fraction VI (2700-3500 mL, 7.6 g) was subjected to a silica gel column (40-63 m, 4.5  40 cm, 2.5 mL/min) eluting with a gradient of EtOAc-hexane (from 30 to 70%) to afford 10 subfractions (VI.1-VI.10). Fraction VI.4 (720-800 mL, 0.2 g) was subsequently separated on a silica gel column (40-63 m, 2.5  30 cm, 2.0 mL/min) with 1-5% of acetone-CH 2 Cl 2 , then subfraction VI.4.3 (480-550 mL, 60 mg) was purified by the same procedure (40-63 m, 1.0  30 cm, 1.0 mL/min) with 20-50% of EtOAc-hexane to yield 4 (28.4 mg). Fraction VI.7 (1300-1500 mL, 0.4 g) was separated on a silica gel column (40-63 m, 2.5  40 cm, 2.0 mL/min) with 50% of EtOAc-hexane, and five subfractions (VI.7.1-VI.7.5) were collected. Subfraction VI.7.1 (100-180 mL, 52.1 mg) was purified by silica gel column chromatography (40-63 m, 1.0  25 cm, 1.0 mL/min) to obtain 2 (20.0 mg). Fraction VIII (3600-4100 mL, 2.0 g) was chromatographed on a silica gel column (40-63 m, 2.5  40 cm, 2.0 mL/min) eluting with a gradient of acetone-hexane (from 20 to 50%) to obtain 12 subfractions (VIII.1-VIII.12). Subfraction VIII.2 (90-170 mL, 120.2 mg) was further purified by silica gel column chromatography (40-63 m, 1.0  20 cm, 1.0 mL/min) with acetone-hexane mixtures (from 30 to 50%) to yield 6 (14.7 mg).
Extraction and isolation of compounds 13, 14, and 30
